These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6244091)

  • 1. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
    Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
    Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells.
    Michelangeli VP; Findlay DM; Moseley JM; Martin TJ
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):129-41. PubMed ID: 6315797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
    Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
    Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106-06) cells.
    Findlay DM; Martin TJ
    J Bone Miner Res; 1986 Jun; 1(3):277-83. PubMed ID: 2845727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
    D'Santos CS; Gatti A; Poyner DR; Hanley MR
    Mol Pharmacol; 1992 May; 41(5):894-9. PubMed ID: 1375316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.
    Findlay DM; Michelangeli VP; Robinson PJ
    Endocrinology; 1989 Nov; 125(5):2656-63. PubMed ID: 2551660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal receptors of parathyroid hormone and calcitonin (author's transl)].
    Ardaillou R
    Nouv Presse Med; 1978 Dec; 7(45):4125-30. PubMed ID: 218163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
    Ng KW; Livesey SA; Larkins RG; Martin TJ
    Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
    Marx SJ; Aurbach GD
    Endocrinology; 1975 Aug; 97(2):448-53. PubMed ID: 169126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
    Hunt NH; Ellison M; Underwood JC; Martin TJ
    Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line.
    Findlay DM; deLuise M; Michelangeli VP; Martin TJ
    J Endocrinol; 1981 Feb; 88(2):271-81. PubMed ID: 6259268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
    Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
    Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcitonin receptor: characterization and processing.
    Raue F; Schneider HG; Ziegler R
    Prog Clin Biol Res; 1990; 332():67-79. PubMed ID: 2158663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amplification of the heterologous response of adenylate cyclase in colonic tumors: relation to tissue lipid composition].
    Bershteĭn LM; Kovaleva IG; Pravosudov IV
    Vopr Med Khim; 1988; 34(3):71-4. PubMed ID: 3420815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells.
    Schneider HG; Raue F; Koppold A; Ruf W; Ziegler R
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):373-8. PubMed ID: 8388616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of catecholamine activation of adenylate cyclase by the number of active beta-adrenergic receptors: theoretical considerations on the role of receptor diffusion in the cell membrane.
    Swillens S
    J Cyclic Nucleotide Res; 1982; 8(2):71-82. PubMed ID: 6294157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-associated changes of the catecholamine-sensitive adenylate cyclase in glioma cells doubly transformed with Moloney sarcoma virus.
    Higashida H; Miki N; Tanaka T; Kato K; Nakano T; Nagatsu T; Kano-Tanaka K
    J Cell Physiol; 1982 Feb; 110(2):107-13. PubMed ID: 6279681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
    Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.